These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37149980)

  • 41. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The tiny big world of solid lipid nanoparticles and nanostructured lipid carriers: an updated review.
    Abdel-Mageed HM; Abd El Aziz AE; Mohamed SA; AbuelEzz NZ
    J Microencapsul; 2022 Jan; 39(1):72-94. PubMed ID: 34958628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid metabolism in Plasmodium falciparum-infected erythrocytes: possible new targets for malaria chemotherapy.
    Mitamura T; Palacpac NM
    Microbes Infect; 2003 May; 5(6):545-52. PubMed ID: 12758284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Overview of Currently Available Antimalarials.
    Gorobets NY; Sedash YV; Singh BK; Poonam ; Rathi B
    Curr Top Med Chem; 2017; 17(19):2143-2157. PubMed ID: 28137228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector.
    Urbán P; Ranucci E; Fernàndez-Busquets X
    Nanomedicine (Lond); 2015 Nov; 10(22):3401-14. PubMed ID: 26582279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and Evaluation of Substituted Poly(organophosphazenes) as a Novel Nanocarrier System for Combined Antimalarial Therapy of Primaquine and Dihydroartemisinin.
    Kumar S; Singh RK; Murthy RS; Bhardwaj TR
    Pharm Res; 2015 Aug; 32(8):2736-52. PubMed ID: 25777611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapeutic advances against malaria in 2003].
    Danis M
    Med Trop (Mars); 2003; 63(3):267-70. PubMed ID: 14579464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-acting injectable atovaquone nanomedicines for malaria prophylaxis.
    Nat Commun; ; . PubMed ID: 29358624
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.